Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality

J Pharm Sci. 2009 Apr;98(4):1201-5. doi: 10.1002/jps.21530.
No abstract available

MeSH terms

  • Consumer Product Safety
  • Drug Contamination / prevention & control*
  • Drug Stability
  • Drug Storage
  • Drug-Related Side Effects and Adverse Reactions
  • Particle Size
  • Pharmaceutical Preparations / administration & dosage
  • Pharmaceutical Preparations / standards*
  • Quality Control
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / standards*

Substances

  • Pharmaceutical Preparations
  • Recombinant Proteins